Sinadjan, Lorissa L.
HRN: 28-68-15 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/08/2026
CEFAZOLIN 1GM (VIAL)
03/08/2026
03/08/2026
IVT
2gms
ON CALL TO OR
STAT COMPLETION CURETTAGE
Pending Pharmacy Acceptance
Indication: Empirical De-escalation Type of Infection: Reproductive Tract Compliance to guidelines: